ImmuPharma (IMM) News Today GBX 3.13 -0.02 (-0.60%) As of 11:46 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period ImmuPharma (LON:IMM) Trading 27.6% Higher - Here's WhyJanuary 20 at 6:09 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading 27.6% Higher - What's Next?January 20 at 5:37 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading Up 27.6% - Time to Buy?January 20 at 5:37 AM | americanbankingnews.comImmuPharma (LON:IMM) Stock Price Up 27.6% - Still a Buy?January 20 at 5:37 AM | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 27.6% - Time to Buy?January 20 at 4:22 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading Up 27.6% - Should You Buy?January 20 at 3:47 AM | americanbankingnews.comImmuPharma (LON:IMM) Stock Price Up 27.6% - Here's What HappenedJanuary 20 at 3:47 AM | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 27.6% - What's Next?January 20 at 3:06 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading Up 27.6% - What's Next?January 20 at 1:25 AM | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 16.2% - Here's What HappenedJanuary 19 at 4:19 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading 14.7% Higher - Here's WhyJanuary 19 at 2:57 AM | americanbankingnews.comImmuPharma (LON:IMM) Trading Up 24.7% - Still a Buy?January 19 at 2:57 AM | americanbankingnews.comImmuPharma PLC (25I.MU)January 19 at 12:59 AM | ca.finance.yahoo.comImmuPharma (LON:IMM) Shares Down 0.1% - Here's What HappenedJanuary 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 4.9% - Should You Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading 4.9% Higher - Here's WhyJanuary 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Stock Price Up 4.9% - Still a Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading Down 1.5% - Here's WhyJanuary 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading Up 4.9% - Should You Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading 4.9% Higher - Here's What HappenedJanuary 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 4.9% - Still a Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading 4.9% Higher - Should You Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Stock Price Up 4.9% - Time to Buy?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 4.9% - What's Next?January 13, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Trading 8.6% Higher - Should You Buy?January 12, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 8.6% - Should You Buy?January 12, 2025 | americanbankingnews.comImmuPharma (LON:IMM) Shares Up 191.7% - Here's WhyJanuary 12, 2025 | americanbankingnews.comSMALL CAP MOVERS: ImmuPharma lifted by groundbreaking researchJanuary 10, 2025 | msn.comAIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflowsJanuary 9, 2025 | lse.co.ukImmuPharma Targets Global Partnerships at Key Biotech EventsJanuary 9, 2025 | markets.businessinsider.comImmuPharma plc (25I.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comImmupharma Share Chat (IMM)September 18, 2024 | lse.co.ukImmuPharma obtains second warrant extension with IncantheraSeptember 10, 2024 | lse.co.ukImmuPharma narrows losses in first half as expenses fallSeptember 10, 2024 | lse.co.ukT42 Iot Track. Share ChatAugust 28, 2024 | lse.co.ukGuardian Metal Resources PLC Share Price (GMET)August 7, 2024 | lse.co.uk5x Long Qqq Share ChatMay 29, 2024 | lse.co.ukHsbc Bk.24 Share ChatMay 26, 2024 | lse.co.ukInvestigational Drugs for Chronic Inflammatory Demyelinating PolyneuropathyMay 8, 2024 | msn.comLooking for top FTSE 100 value shares? Here’s one I’d buy without hesitationMay 8, 2024 | msn.comImmupharma jumps amid new IP strategy for P140 technology platformApril 2, 2024 | lse.co.ukIncanthera says first order from skincare deal doublesMarch 25, 2024 | lse.co.ukSMALL CAP MOVERS: Versarien soars as advanced materials group offloads non-core assetsMarch 15, 2024 | msn.comImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developmentsMarch 8, 2024 | finance.yahoo.comImmuPharma PLC IMMFebruary 24, 2024 | morningstar.comUK government borrowing surplus rises in January from prior yearFebruary 21, 2024 | lse.co.ukImmuPharma PLC (25I.SG)January 17, 2024 | ca.finance.yahoo.comEARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrowsDecember 19, 2023 | lse.co.ukImmuPharma launches GBP2 million fund raise as interim loss narrowsAugust 31, 2023 | lse.co.ukImmuPharma to Raise up to GBP1.85 Mln to Fund R&D Pipeline, Working CapitalAugust 31, 2023 | marketwatch.com Get ImmuPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address IMM Media Mentions By Week IMM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMM News Sentiment▼0.170.60▲Average Medical News Sentiment IMM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMM Articles This Week▼130▲IMM Articles Average Week Get ImmuPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ETX News OBI News POLB News SAR News AREC News OPTI News ONC News FAB News IXI News SNG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:IMM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuPharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
